Scellex

Scellex

Private
HelsinkiHealthcare & Life Scienceshttps://scellex.com/

Last Round

Angel

Apr 1, 2024

Total Funding Raised

$54,000

Company Overview

Scellex is a discovery tools (healthcare) company that has developed a novel spatial gene sequencing technology intended to link microscope images to sequence data and provides RNA-seq services.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Application

Keywords

spatial transcriptomicssingle-cell omicsspatial omicsgene expression analysisspatial gene sequencingsingle-cell analysiscancer research toolsvisual barcodingpicowell arraysRNA sequencingspatial biologydrug discovery toolsRNA-seq servicebiotech equipment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Scellex Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Scellex Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
AngelApr 1, 2024
GrantJun 25, 2020
AcceleratorJun 8, 2020

Scellex Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 1, 2024

    Raised an Angel round with Jean de Gunzburg and Tuomas Tenkanen.

  • Jun 25, 2020

    $54K grant received from Instrumentarium Science Foundation.

Scellex Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Scellex Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Scellex's valuation, stock price, and market status.

Firmographic Details

HeadquartersHelsinki
Year Founded2018
Last FundingApr 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.